Odonate Therapeutics, Inc.
ODTDelisted Jan 25, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001717452
Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Odonate Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 8 | 0 | −8 |
| Shares | 5.41M | 0 | −5.41M (−100.0%) |
| Value | $7.13M | $0 | −$7.13M (−100.0%) |
New holders (0)
Institutions that held Odonate Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (8)
Institutions that held Odonate Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5.55M |
| Samsara BioCapital, LLC | 700,421 | $925.0K |
| Acadian Asset Management LLC | 384,995 | $506.0K |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91.0K |
| Tower Research Capital LLC (TRC) | 43,752 | $58.0K |
| Simplex Trading, LLC | 2,000 | $2.00K |
| Bessemer Group Inc | 230 | $0 |
| Newbridge Financial Services Group, Inc. | 47 | $0 |